tm logo
SENESCEA
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 02 Jul 2024

Last Applicant/ Owned by

12278 Scripps Summit Drive

San Diego

CA

92131

Serial Number

97577353 filed on 02th Sep 2022

Registration Number

N/A

Correspondent Address

Jared M. Barrett

Jared M. Barrett SEED IP LAW GROUP LLP

SUITE 5400

SEATTLE, WA 98104

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SENESCEA

medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials providing health and medical information; providing a website featuring health and medical information reagents for research purposes for drug discovery and development; Diagnostic reagents for clinica Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


providing health and medical information; providing a website featuring health and medical information


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


medical and medical clinical research and development for others in the field of cellular rejuvenation; medical and scientific research, namely, conducting preclinical research and clinical trials


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and therapeutic agents for use in cellular regeneration and cellular rejuvenation; pharmaceutical and therapeutic agents for the treatment of age-related diseases, and the treatment of degenerative diseases; pharmaceutical and therapeutic agents for use in targeting or regulating senescent cells; pharmaceutical and therapeutic agents designed to directly target and regulate senescent cells for cellular regeneration, cellular rejuvenation to restore cell health, treatment of age-related diseases, treatment of degenerative diseases, anti-aging treatments, treatments to reverse human disease, and treatment of human disease; cells for regenerative medicine for the treatment of age-related diseases, treatment of degenerative diseases, anti-aging, to reverse human disease, and to directly target and regulate senescent cells; clinical medical reagents


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


reagents for research purposes for drug discovery and development; Diagnostic reagents for clinical or medical laboratory use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97577353

Mark Type

No Service Mark

Attorney Docket Number

No 321051.20001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Dec 2024SOU TEAS EXTENSION RECEIVED
02th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th May 2024PUBLISHED FOR OPPOSITION
17th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
11th Mar 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
11th Mar 2024TEAS/EMAIL CORRESPONDENCE ENTERED
11th Mar 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Jan 2024NOTIFICATION OF FINAL REFUSAL EMAILED